Yaru Shi, Katrina M. Nolan, Robert L. Burton, Tulin Shekar, Rocio D. Murphy, Natalie Banniettis, . . . Ulrike K. Buchwald. (2023). The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYaru Shi, Katrina M. Nolan, Robert L. Burton, Tulin Shekar, Rocio D. Murphy, Natalie Banniettis, Luwy Musey, and Ulrike K. Buchwald. The 15-valent Pneumococcal Conjugate Vaccine V114 Induces Cross-reactive Antibodies Against Pneumococcal Serotype 6C. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationYaru Shi, et al. The 15-valent Pneumococcal Conjugate Vaccine V114 Induces Cross-reactive Antibodies Against Pneumococcal Serotype 6C. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.